相关实验视频
Updated: May 13, 2025

09:44
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
19.1K
在巴托克索宾治疗突发感神经听力损失后急性心肌梗塞:病例报告
Yinping Lu1, Yingxin Liu1, Weiliang Tang2
1Department of Otorhinolaryngology, Shaoxing People's Hospital, Shaoxing, Zhejiang Province, China.
Medicine
|April 14, 2025
概括
对于突然的感觉神经听力损失 (SSNHL) 的巴托克索宾治疗可能会增加急性心肌梗塞 (AMI) 的风险,因为它对纤维素素水平的影响. 在巴托克索宾治疗期间,仔细监测血栓形成是必不可少的.
科学领域:
- 心脏病学 心脏病学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 巴特罗克索宾用于通过减少纤维素原来改善突然感觉神经听力损失 (SSNHL) 的微循环.
- 巴托克索宾的安全性和有效性,特别是其血栓性潜力,需要进一步研究.
- 本案例报告强调了与巴托克索宾治疗SSNHL相关的潜在不良事件.
研究的目的:
- 报告第一个急性心肌梗塞 (AMI) 病例,该病例是在 SSNHL 治疗巴托克索宾后出现的.
- 评估巴托克索宾在SSNHL患者中的临床安全性.
- 强调在巴托克索宾治疗期间监测纤维素素水平和血栓形成风险的重要性.
主要方法:
- 一名61岁的男性患有严重的SSNHL接受了巴托克索宾治疗.
- 患者在住院期间发生了AMI,血纤维素素水平持续低.
- 进行了穿皮冠状动脉干预,以解决冠状动脉血栓.
主要成果:
- 患者经历了AMI,归因于巴托克索宾诱导的低纤维素素水平.
- 成功的穿皮冠状动脉干预缓解了症状.
- 患者在没有AMI复发的情况下出院.
结论:
- 巴特罗克索宾的复杂药理需要仔细考虑二次血栓形成风险.
- 在巴托克索宾治疗期间,保持适当的纤维素素水平至关重要.
- 这一案例强调了对巴托克索宾的潜在血栓性并发症的警的必要性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
424
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
424
Hearing
51.2K
When we hear a sound, our nervous system is detecting sound waves—pressure waves of mechanical energy traveling through a medium. The frequency of the wave is perceived as pitch, while the amplitude is perceived as loudness.
51.2K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K

